UiPath Crecimiento futuro

Future controles de criterios 1/6

Se prevé un crecimiento anual de los beneficios y los ingresos de UiPath de 19.3% y 9.7% por año respectivamente. Se prevé que el BPA crezca en un 25.9% al año. Se espera que la rentabilidad financiera sea de 0.8% en 3 años.

Información clave

19.3%

Tasa de crecimiento de los beneficios

25.9%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Software17.3%
Tasa de crecimiento de los ingresos9.7%
Rentabilidad financiera futura0.8%
Cobertura de analistas

Good

Última actualización22 Nov 2024

Actualizaciones recientes sobre el crecimiento futuro

Earnings Update: UiPath Inc. (NYSE:PATH) Just Reported And Analysts Are Trimming Their Forecasts

Jun 01
Earnings Update: UiPath Inc. (NYSE:PATH) Just Reported And Analysts Are Trimming Their Forecasts

Recent updates

UiPath: Will Become A Different Company

Nov 17

UiPath: Buy For Strong Recovery Potential, Future Enterprise AI Growth

Oct 28

UiPath: Great Opportunity To Buy This AI Stock At A Cheap Price

Oct 14

UiPath Inc.'s (NYSE:PATH) Share Price Could Signal Some Risk

Oct 04
UiPath Inc.'s (NYSE:PATH) Share Price Could Signal Some Risk

UiPath Inc.: Bullish Support Is Finally Here - Turnaround Likely Prolonged

Sep 14

UiPath Q2 Earnings: On The Path Higher (Rating Upgrade)

Sep 06

Why UiPath Inc. (NYSE:PATH) Could Be Worth Watching

Aug 23
Why UiPath Inc. (NYSE:PATH) Could Be Worth Watching

UiPath: Fighting Headwinds With Strong Fundamentals And AI Optionality

Aug 13

UiPath: Not Your Path To Profits

Aug 05

Calculating The Fair Value Of UiPath Inc. (NYSE:PATH)

Aug 02
Calculating The Fair Value Of UiPath Inc. (NYSE:PATH)

UiPath: On The Long Road To Recovery

Jul 13

UiPath Crashes On Generative AI Headwinds: Buy The Fear (Ratings Upgrade)

Jun 30

Earnings Update: UiPath Inc. (NYSE:PATH) Just Reported And Analysts Are Trimming Their Forecasts

Jun 01
Earnings Update: UiPath Inc. (NYSE:PATH) Just Reported And Analysts Are Trimming Their Forecasts

The Price Is Right For UiPath Inc. (NYSE:PATH) Even After Diving 37%

May 31
The Price Is Right For UiPath Inc. (NYSE:PATH) Even After Diving 37%

UiPath Earnings: It Would Be A Sin To Compound My Mistake (Rating Downgrade)

May 30

UiPath Q1 Earnings Preview: Enterprise Demand Should Sustain

May 24

UiPath: A Hold Based On Demystifying The AI Hype (Rating Downgrade)

Apr 24

UiPath: Still Unloved

Apr 18

UiPath: Post-Earnings Selloff Is A Gift, Positive GAAP Income, Net Cash (Upgrade)

Mar 20

Why Investors Shouldn't Be Surprised By UiPath Inc.'s (NYSE:PATH) P/S

Feb 28
Why Investors Shouldn't Be Surprised By UiPath Inc.'s (NYSE:PATH) P/S

UiPath: I Am Not Ready To Pay Premium Here

Feb 19

Is UiPath Inc. (NYSE:PATH) Potentially Undervalued?

Feb 01
Is UiPath Inc. (NYSE:PATH) Potentially Undervalued?

UiPath: Leader In An Unloved Segment

Jan 16

UiPath's Bots Make Generative AI Apps Work Better

Jan 09

UiPath: From IPO Hype To Market Leadership, And Challenges Ahead

Dec 29

A Look At The Fair Value Of UiPath Inc. (NYSE:PATH)

Nov 27
A Look At The Fair Value Of UiPath Inc. (NYSE:PATH)

UiPath: Correction Over; Outperformance Ahead

Nov 26

UiPath May Beat Expectations Again, Staying Expensive

Nov 20

UiPath: Left Underappreciated

Oct 16

UiPath: The Real AI Pioneer

Sep 14

UiPath Q2 2024 Earnings Preview: I Expect FY24 Guidance To Be Raised

Sep 05

Previsiones de crecimiento de beneficios e ingresos

NYSE:PATH - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
1/31/20271,757-1263843798
1/31/20261,580-14235435722
1/31/20251,423-17232533022
7/31/20241,383-112327334N/A
4/30/20241,354-87325332N/A
1/31/20241,308-90292299N/A
10/31/20231,211-151242247N/A
7/31/20231,148-178168178N/A
4/30/20231,103-23894110N/A
1/31/20231,059-328-34-10N/A
10/31/20221,040-364-135-110N/A
7/31/2022998-429-132-108N/A
4/30/2022951-408-109-90N/A
1/31/2022892-526-67-55N/A
10/31/2021810-436-42-31N/A
7/31/2021737-384-52N/A
4/30/2021681-2843036N/A
1/31/2021608-922629N/A
1/31/2020336-520-380-359N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que PATH siga sin ser rentable en los próximos 3 años.

Beneficios vs. Mercado: Se prevé que PATH siga sin ser rentable en los próximos 3 años.

Beneficios de alto crecimiento: Se prevé que PATH siga sin ser rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (9.7% al año) de PATH crezcan más rápidamente que los del mercado US (8.9% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 9.7% al año) de PATH crezcan más despacio que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de PATH sea baja dentro de 3 años (0.8%).


Descubre empresas en crecimiento